Patent application number | Description | Published |
20130217888 | PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE - The present invention provide processes for the preparation of Bendamustine hydrochloride monohydrate of formula (I) | 08-22-2013 |
20130281739 | FINGOLIMOD POLYMORPHS AND THEIR PROCESSES - The present invention provides crystalline polymorphic forms of Fingolimod HCl (I) and processes for preparation thereof. | 10-24-2013 |
20140039209 | PROCESS FOR PREPARING DOCETAXEL AND ITS HYDRATE - The present invention provide process of preparation of (2R,3S)—N-carboxy-3-phenylisoserine, N-tert-butyl ester, 13-ester with 5(β)-20-epoxy-1,2(α),4,7(β),10(β),13(α)-hexa hydroxy tax-11-en-9-one 4-acetate 2-benzoate or docetaxel and its trihydrate (I) | 02-06-2014 |
20140336246 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL - The present invention provides a non-solvated amorphous form of (2α,5β,7β,10β,13α)-4-acetoxy-13-({(2R,3S)-3[ (tert-butoxy carbonyl) amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate or Cabazitaxel (I), | 11-13-2014 |
20150175554 | Highly pure bendamustine hydrochloride monohydrate - The present invention provide processes for the preparation of highly pure Bendamustine hydrochloride monohydrate of formula (I) | 06-25-2015 |
20150259364 | CRYSTALLINE BORTEZOMIB PROCESS - The present invention provides process for preparation of crystalline Bortezomib (Ia) as its monohydrate which is designated as crystalline Form-SB | 09-17-2015 |
20150299141 | Crystalline Erlotinib Hydrochloride Process - The present invention provides process for preparation of Crystalline Erlotinib HCl (I) Form-SE | 10-22-2015 |
20150344409 | PROCESS FOR THE PREPARATION OF FINGOLIMOD AND ITS SALTS - The present invention provides process for preparation of Fingolimod hydrochloride (I). | 12-03-2015 |